Treatment benefit of tivozanib hydrochloride versus sorafenib on health-related quality of life (HRQoL) among patients (pts) with advanced/metastatic renal cell carcinoma (mRCC): TIVO-1 study results Meeting Abstract
| Authors: | Cella, D.; Ivanescu, C.; Skaltsa, K.; Casamayor, M.; Strahs, A. L.; Esteves, B.; Berkenblit, A.; Motzer, R. J. |
| Abstract Title: | Treatment benefit of tivozanib hydrochloride versus sorafenib on health-related quality of life (HRQoL) among patients (pts) with advanced/metastatic renal cell carcinoma (mRCC): TIVO-1 study results |
| Meeting Title: | 2013 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2013 Feb 14-16 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-02-20 |
| Language: | English |
| ACCESSION: | WOS:000333679600353 |
| DOI: | 10.1200/jco.2013.31.6_suppl.355 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 355 -- Source: Wos |
